$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Methods and compositions for treating viral diseases 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-031/553
  • A61K-031/517
  • A61K-031/404
  • C12Q-001/18
출원번호 US-0362993 (2012-12-06)
등록번호 US-9364484 (2016-06-14)
국제출원번호 PCT/US2012/068167 (2012-12-06)
국제공개번호 WO2013/086133 (2013-06-13)
발명자 / 주소
  • Einav, Shirit
  • Barouch-Bentov, Rina
  • Neveu, Gregory
  • Zivav, Amotz
출원인 / 주소
  • The Board of Trustees of the Leland Stanford Junior University
대리인 / 주소
    Roberts Foster LLP
인용정보 피인용 횟수 : 0  인용 특허 : 62

초록

The invention provides a method for treating viral infections and coinfections through the use of inhibitory agents that prevent a unique viral structural protein motifs from binding to host proteins from the clathrin adaptor proteins family and subsequently preventing viral replication.

대표청구항

1. A method of inhibiting infections by a Lentiviridae, HIV, HCV/HIV co-infection, Flaviviridae other than HCV, clathrin AP binding viruses other than Flaviviridae, or clathrin AP binding viruses other than HCV, the method comprising administering to a patient in need thereof an effective amount of

이 특허에 인용된 특허 (62)

  1. Greenwald Richard B. ; Gilbert Carl W., .alpha.-interferon-polymer-conjugates having enhanced biological activity and methods of preparing the same.
  2. Ganguly Ashit K. ; McCormick Jinping ; Lovey Raymond G. ; Bennett Frank ; Saksena Anil K. ; Girijavallabhan Viyyoor M., 5'-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon.
  3. Heruth Kenneth T., Apparatus for drug infusion implanted within a living body.
  4. Lippe Barbara ; Holte Anders,SEX ; Himbert Hans,SEX ; Hjertman Birger,SEX ; Pavlu Bohdan,SEX ; Westermark Magnus,SEX ; Bosse Rainer,CHX ; Adam Markus,CHX, Automated delivery device and method for its operation.
  5. Zhang, Rumin, Azapeptides useful in the treatment of Hepatitis C.
  6. Thompson Howard J. (New Richmond WI), Body implantable medical infusion system.
  7. Stabinsky Yitzhak (Boulder CO), Consensus human leukocyte interferon.
  8. Stabinsky Yitzhak (Boulder CO), Consensus human leukocyte interferon.
  9. Robert Tam ; Guangyi Wang ; Devron Averett ; Kandasamy Ramasamy, Cytokine related treatments of disease.
  10. Eckenhoff James B. (Los Altos CA), Delivery device providing beneficial agent stability.
  11. Magruder Judy A. (Mountain View CA) Peery John R. (Palo Alto CA) Eckenhoff James B. (Los Altos CA), Delivery device with a protective sleeve.
  12. Magruder Judy A. (Mountain View CA) Peery John R. (Palo Alto CA) Eckenhoff James B. (Los Altos CA), Delivery device with a protective sleeve.
  13. Magruder Judy A. (Mt. View CA) Eckenhoff James B. (Los Altos CA) Cortese Richard (Los Gatos CA) Wright Jeremy C. (Los Altos CA) Peery John R. (Palo Alto CA), Delivery system comprising biocompatible beneficial agent formulation.
  14. Magruder Judy A. (Mt. View CA) Eckenhoff James B. (Los Altos CA) Cortese Richard (Los Gatos CA) Wright Jeremy C. (Los Altos CA) Perry John R. (Palo Alto CA), Delivery system for beneficial agent over a broad range of rates.
  15. Michaels Alan S. (San Francisco CA), Device for delivering drug to a fluid environment.
  16. Fischell Robert E. ; Fischell David R. ; Fischell Tim A., Device for subcutaneous medication delivery.
  17. Theeuwes Felix (Los Altos CA), Device having variable volume chamber for dispensing useful agent.
  18. Duggan Stephen R. (Rosemount MN), Drug administration device.
  19. Peterson Thomas L. ; Blomquist Michael L., Drug pump systems and methods.
  20. Thomas L. Peterson ; Michael L. Blomquist, Drug pump systems and methods.
  21. Llinas-Brunet Montse,CAX ; Bailey Murray D.,CAX ; Halmos Teddy,CAX ; Poupart Marc-Andre,CAX ; Tsantrizos Youla,CAX, Hepatitis C inhibitor peptide analogues.
  22. Llinas-Brunet Montse,CAX ; Bailey Murray D.,CAX ; Cameron Dale R.,CAX ; Ghiro Elise,CAX ; Goudreau Nathalie,CAX ; Poupart Marc-Andre,CAX ; Rancourt Jean,CAX ; Tsantrizos Youla S.,CAX ; Faucher Anne-M, Hepatitis C inhibitor tri-pepitides.
  23. Llinas-Brunet Montse,CAX ; Bailey Murray D.,CAX ; Cameron Dale R.,CAX ; Ghiro Elise,CAX ; Goudreau Nathalie,CAX ; Poupart Marc-Andre,CAX ; Rancourt Jean,CAX ; Tsantrizos Youla S.,CAX ; Faucher Anne-M, Hepatitis C inhibitor tri-peptides.
  24. Llinas-Brunet Montse,CAX ; Bailey Murray D.,CAX ; Cameron Dale,CAX ; Ghiro Elise,CAX ; Goudreau Nathalie,CAX ; Poupart Marc-Andre,CAX ; Rancourt Jean,CAX ; Tsantrizos Youla S.,CAX ; Faucher Anne-Mari, Hepatitis C inhibitor tri-peptides.
  25. Llinas-Brunet, Montse; Bailey, Murray D.; Cameron, Dale R.; Ghiro, Elise; Goudreau, Nathalie; Poupart, Marc-Andre; Rancourt, Jean; Tsantrizos, Youla S.; Faucher, Anne-Marie; Halmos, Teddy; Wernic, Do, Hepatitis C inhibitor tri-peptides.
  26. Llinas-Brunet, Montse; Gorys, Vida J., Hepatitis C inhibitor tri-peptides.
  27. Montse Llinas-Brunet CA; Murray D. Bailey CA; Dale R. Cameron CA; Elise Ghiro CA; Nathalie Goudreau CA; Marc-Andre Poupart CA; Jean Rancourt CA; Youla S. Tsantrizos CA; Anne-Marie Faucher CA, Hepatitis C inhibitor tri-peptides.
  28. Montse Llinas-Brunet CA; Murray D. Bailey CA; Dale R. Cameron CA; Ellse Ghiro CA; Nathalie Goudreau CA; Marc-Andre Poupart CA; Jean Rancourt CA; Youla S. Tsantrizos CA; Anne-Marie Faucher CA, Hepatitis C inhibitor tri-peptides.
  29. Magruder Judy A. (Mt. View CA) Eckenhoff James B. (Los Altos CA) Wright Jeremy C. (Los Altos CA), Implantable delivery dispenser.
  30. Fox, James K.; Rottenberg, William B.; Thome, Bryan J., Implantable device and programmer system which permits multiple programmers.
  31. Akira Ishikawa ; Nabuo Takeda ; Suzanne I. Ahn ; Samuel S. Ahn ; Steven R. Hayes ; F. Andrew Gaffney, Implantable drug delivery system.
  32. Portner Peer M. (Kensington CA) Jassawalla Jal S. (San Francisco CA), Implantable infusion device.
  33. Steinbach Bernd,DEX ; Walter Claus,DEX, Implantable infusion pump.
  34. Harris Donald L. (Miami Beach FL), Implantable microinfusion pump system.
  35. Torgerson Nathan A. ; McMullen Raymond F., Implantable non-invasive rate-adjustable pump.
  36. Rise Mark T. (Monticello MN), Implantable techniques for infusing a therapeutic agent with endogenous bodily fluid.
  37. Tung, Roger D.; Bhisetti, Govinda Rao; Farmer, Luc J., Inhibitors of serine proteases, particularly HCV NS3 protease.
  38. Tung Roger D. ; Harbeson Scott L. ; Deininger David D. ; Murcko Mark A. ; Bhisetti Govinda R. ; Farmer Luc J., Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease.
  39. Tung, Roger D; Harbeson, Scott L.; Deininger, David D.; Murcko, Mark A.; Bhisetti, Govinda R.; Farmer, Luc J., Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease.
  40. Gilbert Carl W. ; Park-Cho Myung-ok,KRX, Interferon polymer conjugates.
  41. Tsantrizos, Youla S.; Cameron, Dale R.; Faucher, Anne-Marie; Ghiro, Elise; Goudreau, Nathalie; Halmos, Teddy; Llinas-Brunet, Montse, Macrocyclic peptides active against the hepatitis C virus.
  42. Kratoska Paul S. (Brooklyn Park MN) Christiansen Chris C. (Oakdale MN), Medication delivery device and method of construction.
  43. Glenn, Jeffrey; Sklan, Ella; Staschke, Kirk A.; Oakes, Tina Myers, Methods and compositions for identifying anti-HCV agents.
  44. Thomas R. Bailey ; Dorothy C. Young, Methods for treating viral infections.
  45. Deters Joseph C. (Mountain View CA) Theeuwes Felix (Los Altos CA) Mullins Kevin J. (Berkeley CA) Eckenhoff James B. (Los Altos CA), Osmotic capsule.
  46. Higuchi Takeru (Lawrence KS), Osmotic device with compartment for governing concentration of agent dispensed from device.
  47. Cortese Richard (San Jose CA) Theeuwes Felix (Los Altos CA), Osmotic device with hydrogel driving member.
  48. Theeuwes Felix (Los Altos CA), Osmotic dispenser with gas generating means.
  49. Higuchi Takeru (Lawrence KS) Leeper Harold M. (Mountain View CA), Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient.
  50. Theeuwes ; Felix, Osmotic system for the controlled and delivery of agent over time.
  51. Theeuwes ; Felix, Osmotic system with means for improving delivery kinetics of system.
  52. Theeuwes Felix (Los Altos CA) Damani Nalinkant C. (Sunnyvale CA), Osmotically driven active agent dispenser.
  53. Eckenhoff James Benjamin (Palo Alto CA) Johnson Neil Arthur (Sunnyvale CA) Yum Su Il (Sunnyvale CA), Osmotically driven fluid dispenser.
  54. Karasiewicz Robert (Parsippany NJ) Nalin Carlo (Franklin Lakes NJ) Rosen Perry (North Caldwell NJ), Peg-interferon conjugates.
  55. Gamblin Rodger L. (Dayton OH) Burchett Roger C. (Miamisburg OH), Random artificially perturbed liquid apparatus and method.
  56. Heruth Kenneth T., Recirculating implantable drug delivery system.
  57. Eckenhoff James B. (Los Altos CA) Urquhart John (Palo Alto CA), Release rate adjustment of osmotic or diffusional delivery devices.
  58. Peery John R. ; Dionne Keith E. ; Eckenhoff James B. ; Landrau Felix A. ; Lautenbach Scott D. ; Magruder Judy A. ; Wright Jeremy C., Sustained delivery of an active agent using an implantable system.
  59. Peery John R. ; Dionne Keith E. ; Eckenhoff James B. ; Landrau Felix A. ; Lautenbach Scott D. ; Magruder Judy A. ; Wright Jeremy C., Sustained delivery of leuprolide using an implantable system.
  60. Zhang Rumin ; Mui Philip W. ; Weber Patricia C., Synthetic inhibitors of hepatitis C virus NS3 protease.
  61. Witkowski Joseph T. (5 Martha Dr. Morris Township ; Morris County NJ 07960) Robins Roland K. (1131 Doven Dr. Provo UT 84602), Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide.
  62. Pierre Louis Beaulieu CA; Gulrez Fazal CA; James Gillard CA; George Kukolj CA; Volkhard Austel DE, Viral polymerase inhibitors.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로